|
[1]Gressner AM, Weiskirchen R.Modern pathogenetic concepts of liverfibrosis suggest stellate cell and TGFβ1as major players and thera-peutic targets[J].J cell Mol Med, 2006, 10 (1) ∶76-99.
|
|
[2]蔡卫民.肝纤维化研究若干进展[J].临床肝胆病杂志, 2006, 22 (3) ∶167-170.
|
|
[3]Friedman SL, Bansal MB.Reveal of hepatic fibrosis-fact or Fantasy[J]?Hepatology, 2006, 43∶S82-S88.
|
|
[4]Ghang MG, Doo E.Assessment of liver fibrosis:Palpate, poke ofpulse[J]?Hepatology, 2005, 42 (4) ∶759-762.
|
|
[5]蔡卫民, 郑敏, 翁红雷, 等.慢性肝炎患者血清纤维化指标的检测及其临床意义[J].中华内科杂志, 2001, 40 (7) ∶448-451.
|
|
[6]蔡卫民, 陶君, 翁红雷, 等.血清纤维化指标影响因素分析[J].中华肝胆病杂志, 2003, 11 (1) ∶22-25.
|
|
[7]ZHANG Bin-bin, CAI Wei-min, WENG Hong-lei, et al.Diag-nostic value of PDGF-BB, TGFβ1, MMP-1 and TINP-1 in ser-um and PBMCs for hepatic fibrosis[J].Word J Gastroenterol, 2003, 9 (11) ∶2490-2496.
|
|
[8]Wai CT, Greenson JK, Fontana BJ, et al.A simple noninvasive in-dex can predict both significant fibrosis and cirrhosis in patients withchronic hepatitis[J].Hepatology, 2003, 38 (2) ∶518-526.
|
|
[9]Cales P, Oberti F, Michalat S, et al.Anovel panel of blood markersto assess the degree of liver fibrosis[J].Hepatology, 2005, 42 (6) ∶1373-1381.
|
|
[10]张文胜, 王宝恩, 王泰龄, 等.慢性乙型肝炎肝纤维化无创性诊断模型的建立[J].中华肝脏病杂志, 2006, 14 (3) ∶169-173.
|
|
[11] 蔡卫民, 孙永良, 张立煌, 等.肝纤维化血清诊断的初步探讨-附612例慢性肝病患者11次血清结果分析[J].中西医结合肝病杂志, 1999, 5 (1) ∶3-6.
|